As Programme Director at Achilles Therapeutics plc, Alex Groundwater leverages over 22 years of extensive experience in strategic planning and business transformation to spearhead critical projects that drive innovation in the biotechnology sector. His current focus is on the development of a state-of-the-art manufacturing facility...
As Programme Director at Achilles Therapeutics plc, Alex Groundwater leverages over 22 years of extensive experience in strategic planning and business transformation to spearhead critical projects that drive innovation in the biotechnology sector. His current focus is on the development of a state-of-the-art manufacturing facility in London, which is poised to enhance the company’s capabilities in producing advanced cell therapies. This project encompasses the intricate design and construction of Grade C clean rooms and ATEX-rated laboratories, alongside essential warehouse and office spaces, ensuring compliance with stringent regulatory standards.
Alex's expertise in management and resource allocation is pivotal as he navigates the complexities of this ambitious undertaking. His proven track record in rescuing failing programmes is instrumental in re-evaluating the existing operating model, allowing for the identification of bottlenecks and the implementation of effective solutions. By employing robust business analysis techniques and leveraging his skills in budget management, Alex ensures that the project remains on track and within financial parameters.
In addition to his project management acumen, Alex is adept in system deployment and offshoring strategies, which are critical in optimizing operational efficiency. His proficiency in e-commerce and infrastructure projects further enhances his ability to align the manufacturing facility's capabilities with the evolving demands of the market. As he guides the project through RIBA Stage III validation and into a fully developed Stage IV technical design, Alex Groundwater exemplifies leadership in the biotechnology field, driving transformative initiatives that not only meet but exceed industry expectations.
